mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
This is a summary aggregated from Ars Technica. Read the complete article on the original site:
Read full article at Ars Technica
